Azidamfenicol
Chemical compound
- S01AA25 (WHO)
- In general: ℞ (Prescription only)
- 2-azido-N-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)acetamide
- 13838-08-9 N
- 62858
- 56590 Y
- 40257685LM
- D07411 Y
- ChEMBL278788 N
- DTXSID90160647
- Interactive image
- [N-]=[N+]=N\CC(=O)N[C@@H]([C@H](O)c1ccc([N+]([O-])=O)cc1)CO
InChI
- InChI=1S/C11H13N5O5/c12-15-13-5-10(18)14-9(6-17)11(19)7-1-3-8(4-2-7)16(20)21/h1-4,9,11,17,19H,5-6H2,(H,14,18)/t9-,11-/m1/s1 Y
- Key:SGRUZFCHLOFYHZ-MWLCHTKSSA-N Y
Azidamfenicol is an amphenicol antibiotic,[1] which has similar profile to chloramphenicol. It is used only topically, as eye drops and ointment for treatment of susceptible bacterial infections.[2]
References
- ^ de Groot AC (2021). "Chaper 3.26: Azidamfenicol". Topical Drugs. Monographs in Contact Allergy. Vol. 3 (First ed.). Boca Raton, FL: CRC Press. p. 79. ISBN 978-1-00-036786-7.
- ^ Sweetman SC (2007). Martindale: The Complete Drug Reference (35th ed.). London: Pharmaceutical Press. ISBN 978-0-85369-687-2.
- v
- t
- e
Aminoglycosides (initiation inhibitors) |
| ||||||
---|---|---|---|---|---|---|---|
Tetracycline antibiotics (tRNA binding) |
|
Steroid antibacterials |
---|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e